Although there is more and more proof that medicinal cannabis could be another option to opioids as far as pain control, another report demonstrates that Congress is still not set up to give scientists the approval to dive into more into this dynamic idea. Just a week ago, the United States House Rules Committee voted against two proposed measures that would have required a unique pain administration team to consider how weed may be utilized as an option or as a part of a mixture that includes prescribed painkillers.
Both measures, put together by Representatives Dana Rohrabacher and Jared Polis, would have given the United State’s new painkiller detail, a team made up of different government drug and health organizations, the chance to investigate “the potential for marijuana to serve as an alternative to opioids for pain management,” and undergo experimentation that compares “the medical application of marijuana and opioids for pain management.”
With an attempt to make understood the significance of permitting the team to incorporate therapeutic cannabis in its research, Polis clarified before the House Committee that medical pot has as of now demonstrated a huge guarantee in preventing overdose occurrences coming from the misuse of opiates.
“Medical marijuana is a possible and likely way to reduce opioid prescription painkiller abuse for chronic pain,” said Polis. “And unfortunately, it’s hardly been explored due to government policy, in large part because of the federal government’s monopoly on legal cultivation and studies.”
Calling attention to various studies, Polis said that while he doesn’t anticipate that restorative marijuana will have a perfect achievement rate with regards to the treatment of serious pain, it merits incorporating into the up and coming government examination in light of the fact that “it does work for some patients.”
“If it can avoid going onto narcotics like opioids, which often lead to abuse, I think it can be an important part of the arsenal in dealing with this plague and epidemic of opioid abuse,” he concluded.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com